{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T12:23:33Z","timestamp":1780489413198,"version":"3.54.1"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2191,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1111\/j.1365-2133.2009.09217.x","type":"journal-article","created":{"date-parts":[[2009,5,12]],"date-time":"2009-05-12T18:01:14Z","timestamp":1242151274000},"page":"654-659","source":"Crossref","is-referenced-by-count":57,"title":["Analysis of interleukin-10 levels in lesions of vitiligo following treatment with topical tacrolimus"],"prefix":"10.1093","volume":"161","author":[{"given":"Z.A.","family":"Taher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Lauzon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Maguiness","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.T.","family":"Dytoc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"10.1111\/j.1365-2133.2009.09217.x-BIB1","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2165\/00128071-200102030-00006","article-title":"Vitiligo. Pathogenesis and treatment","volume":"2","author":"Njoo","year":"2001","journal-title":"Am J Clin Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09217.x-BIB2","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1067\/mjd.2001.109810","article-title":"Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part I, efficacy","volume":"44","author":"Hanifin","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09217.x-BIB3","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1067\/mjd.2001.109812","article-title":"Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children","volume":"44","author":"Kang","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09217.x-BIB4","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1067\/mjd.2002.126250","article-title":"Topical tacrolimus for repigmentation of vitiligo","volume":"47","author":"Grimes","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09217.x-BIB5","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1159\/000065845","article-title":"Repigmentation of vitiligo with topical tacrolimus","volume":"205","author":"Smith","year":"2002","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2133.2009.09217.x-BIB6","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1365-2230.2004.01632.x","article-title":"Topical tacrolimus for treatment of childhood vitiligo in Asians","volume":"29","author":"Kanwar","year":"2004","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09217.x-BIB7","first-page":"581","article-title":"A double-blind randomized trial of 0.1% tacrolimus vs. 0.05% clobetasol for the treatment of childhood vitiligo","volume":"139","author":"Lepe","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09217.x-BIB8","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.jaad.2004.05.036","article-title":"Tacrolimus ointment promotes repigmentation of vitiligo in children: a review of 57 cases","volume":"51","author":"Silverberg","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09217.x-BIB9","first-page":"1219","article-title":"Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance","volume":"148","author":"Le Poole","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1111\/j.1365-2133.2009.09217.x-BIB10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0923-1811(99)00029-8","article-title":"Levels of soluble interleukin-2 receptor in the sera and skin tissue fluids of patients with vitiligo","volume":"21","author":"Caixia","year":"1999","journal-title":"J Dermatol Sci"},{"key":"10.1111\/j.1365-2133.2009.09217.x-BIB11","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0198-8859(00)00152-X","article-title":"Switch from cyclosporine A to tacrolimus in renal transplant recipients: impact on Th1, Th2, and monokine responses","volume":"61","author":"Weimer","year":"2000","journal-title":"Hum Immunol"},{"key":"10.1111\/j.1365-2133.2009.09217.x-BIB12","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s000110050500","article-title":"Differential IL-10 receptor gene expression in acute versus chronic atopic eczema. Modulation by immunosuppressive drugs and cytokines in normal cultured keratinocytes","volume":"48","author":"Muschen","year":"1999","journal-title":"Inflamm Res"},{"key":"10.1111\/j.1365-2133.2009.09217.x-BIB13","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2165\/00003495-200565040-00002","article-title":"New treatment modalities for vitiligo","volume":"4","author":"Kostovic","year":"2005","journal-title":"Drugs"},{"key":"10.1111\/j.1365-2133.2009.09217.x-BIB14","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2165\/00128071-200203050-00001","article-title":"Vitiligo: a manifestation of apoptosis?","volume":"3","author":"Huang","year":"2002","journal-title":"Am J Clin Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09217.x-BIB15","doi-asserted-by":"crossref","first-page":"7284","DOI":"10.4049\/jimmunol.151.12.7284","article-title":"A novel, antigen-presenting function of melanocytes and its possible relationship to hypopigmentary disorders","volume":"151","author":"Le Poole","year":"1993","journal-title":"J Immunol"},{"key":"10.1111\/j.1365-2133.2009.09217.x-BIB16","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/1523-1747.ep12476645","article-title":"Presence or absence of melanocytes in vitiligo lesions: an immunohistochemical investigation","volume":"100","author":"Le Poole","year":"1993","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09217.x-BIB17","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jaad.2003.12.031","article-title":"Topical tacrolimus therapy for vitiligo: therapeutic responses and skin messenger RNA expression of proinflammatory cytokines","volume":"52","author":"Grimes","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09217.x-BIB18","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S1567-5769(01)00059-5","article-title":"Tacrolimus suppressed the production of cytokines involved in atopic dermatitis by direct stimulation of human PBMC system. (Comparison with steroids)","volume":"1","author":"Sakuma","year":"2001","journal-title":"Int Immunopharmacol"},{"key":"10.1111\/j.1365-2133.2009.09217.x-BIB19","first-page":"201","article-title":"Calcineurin antagonists inhibit interferon-gamma production by downregulation of interleukin-18 in human mixed lymphocyte reactions","volume":"54","author":"Kuinose","year":"2000","journal-title":"Acta Med Okayama"},{"key":"10.1111\/j.1365-2133.2009.09217.x-BIB20","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0022-3565(24)37006-5","article-title":"FK-506 and cyclosporin A potentiate the IgE antibody production by contact sensitization with hapten in mice","volume":"283","author":"Nagai","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/j.1365-2133.2009.09217.x-BIB21","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0091-6749(98)70281-7","article-title":"A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children. Pediatric Tacrolimus Study Group","volume":"102","author":"Boguniewicz","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1365-2133.2009.09217.x-BIB22","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1067\/mjd.2001.109817","article-title":"Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part II, safety","volume":"44","author":"Soter","year":"2001","journal-title":"J Am Acad Dermatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2009.09217.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2009.09217.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T11:04:07Z","timestamp":1739099047000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/161\/3\/654\/6642045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,9]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2009.09217.x","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}